Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: a sub-analysis of the SUPPRESS-AF trial.
Matsuda Y, Masuda M, Mano T, Tsujimura T, Uematsu H, Ooka H, Kudo S, Ochi M, Okamoto S, Ishihara T, Nanto K, Hata Y, Nakao S, Kusuda M, Ariyasu W, Sunaga A, Tanaka N, Watanabe T, Minamiguchi H, Egami Y, Oka T, Minamisaka T, Kanda T, Okada M, Kawasaki M, Tanaka K, Makino N, Kida H, Hikoso S, Dohi T, Inoue K, Sotomi Y, Sakata Y; Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators.
Matsuda Y, et al. Among authors: sunaga a.
Europace. 2025 Sep 1;27(9):euaf205. doi: 10.1093/europace/euaf205.
Europace. 2025.
PMID: 40892973
Free PMC article.
Clinical Trial.